The FY 2027 inpatient payment rule, finalized July 31, 2026 and effective October 1, 2026, does something easy to miss in a two-thousand-page document. It nationalizes the Comprehensive Care for Joint Replacement model, with mandatory participation beginning January 2028.
Put that next to the Transforming Episode Accountability Model, which has covered more than seven hundred CMS-selected hospitals since January 2026 and has now expanded to additional spinal fusion episodes.
Episode-based accountability is going from selected to universal. If your product reduces episode cost, manages care transitions, or prevents thirty-day readmissions, your addressable market stops being a CMS selection list and becomes a market.
This is one of the few genuine expansions in this rulemaking cycle. Most of what CMS did in the summer of 2026 narrows something.
Two notes on how to sell into it. The hospitals that will be mandated in 2028 are modeling it now, in the current budget cycle — the buying conversation is live well ahead of the deadline. And the argument that works is not an ROI model. It is avoiding a repayment.